For patients at risk of developing OHSS, controlled ovarian stimulation protocols using GnRH antagonists followed by GnRH agonist triggers and freeze-all strategies are recommended to reduce the likelihood of severe cases [51]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.